How big is the Netherlands Pharmaceutical Market?

The Netherlands Pharmaceutical Market size is expected to reach USD 9.92 billion in 2024 and grow at a CAGR of 7.5% to reach USD 14.24 billion by 2029. Read More

What is the current Netherlands Pharmaceutical Market size?

In 2024, the Netherlands Pharmaceutical Market size is expected to reach USD 9.92 billion. Read More

Who are the key players in Netherlands Pharmaceutical Market?

Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Novartis AG and F. Hoffmann-La Roche AG are the major companies operating in the Netherlands Pharmaceutical Market. Read More

What years does this Netherlands Pharmaceutical Market cover, and what was the market size in 2023?

In 2023, the Netherlands Pharmaceutical Market size was estimated at USD 9.18 billion. The report covers the Netherlands Pharmaceutical Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Netherlands Pharmaceutical Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Netherlands Pharmaceutical Market Share

Statistics for the 2023 & 2024 Netherlands Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Netherlands Pharmaceutical share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Netherlands Pharmaceutical Industry

The Dutch pharmaceutical market is moderately fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies which are currently dominating the market are Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma, AstraZeneca PLC, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, and Pfizer Inc.